分子交差点:乳がんにおけるSMADとドーパミン経路を橋渡しするMAPKタンパク質の識別
Przemysław Borawski1,2, Tomasz Sirek2,3,4, Agata Sirek2
1Independent Researcher, Włocławek, Poland.
Cell cycle (Georgetown, Tex.)
|August 28, 2025
まとめ
この研究では,乳がんにおけるMAPK,SMAD,ドーパミン経路の間の重要な分子関連が明らかにされ,潜在的な治療標的が特定されました. 研究者達は 特定の遺伝子とマイクロRNAを 発見し 信号のカスケードに橋渡しし 治療の新たな道を開きました
科学分野:
- 分子生物学
- 腫瘍学
- 生物化学
背景:
- トランスフォーマー成長因子β (TGF-β) /SMADシグナル伝達経路,ミトゲン活性化タンパク質キナーゼ (MAPK) シグナル伝達カスケード,ドーパミン受容体の活動は,腫瘍の進行に寄与すると認識されています.
- これらの経路の間の分子相互作用を理解することは 乳がんの病原性を解読するのに不可欠です
研究 の 目的:
- 乳がんにおけるTGF-β/SMAD,MAPK,ドーパミンシグナル伝達経路の分子相互作用を調査する.
- SMADとドーパミンのシグナル伝達を繋ぐ特定のMAPKタンパク質を特定する.
- 乳がんの潜在的バイオマーカーと 治療標的を これらの分子交差点に基づいて発見する.
主な方法:
- 405人の乳がん患者で 分子サブタイプを用いたトランスクリプトミカルプロファイリング
- 差異的に発現する遺伝子を特定するためのバイオインフォマティクスベースのネットワーク分析.
- 定量的な逆転写ポリメラーゼ連鎖反応 (qRT-PCR) とタンパク質発現分析による酵素関連免疫吸収試験 (ELISA) を用いた鍵トランスクリプトの検証.
- マイクロRNA (miRNA) 調節相互作用の分析
主要な成果:
- 167の異なる発現の遺伝子が特定され,14の遺伝子はすべてのサブタイプで一貫して変化し,CDC42,KRAS,TGFB1が上昇調節され,FGF2,FGF7,IGF1が低下調節された.
- miRNA分析では,miR-221,miR-222,およびmiR-16-5pが重要な調節因子として関与している.
- ELISAでは,KIT,IGF1,FGFファミリータンパク質の減少と,腫瘍組織におけるKRASタンパク質の発現の有意な上昇が確認されました.
- タンパク質の相互作用分析により,MAPK,SMAD,ドーパミンシグナル伝達を結びつける重要なハブが示されました.
結論:
- この研究では,乳がんにおけるMAPK,SMAD,ドーパミン経路の重要な分子交差点を明らかにしました.
- 特定遺伝子やmiRNAを含む,特定された分子要因は,乳がん治療の潜在的なバイオマーカーと治療標的を表しています.
関連する概念動画
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K


